4D Molecular Therapeutics Inc (FDMT)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -19.699 | -63.537 | -32.717 | -22.223 | -34.938 | -33.515 |
| Return on Equity (%) | 69.243 | 98.066 | -61.819 | -24.785 | -39.057 | -37.405 |
| Return on Invested Capital (%) | -27.744 | -7709.036 | -62.221 | -28.159 | -46.212 | -43.282 |
| Operating Margin (%) | -67.594 | -705.783 | -416.493 | -395.371 | -3435.411 | -486.595 |
| Net Profit Margin (%) | -67.594 | -705.783 | -416.493 | -395.371 | -3435.411 | -486.595 |
| Book Value Per Share | 14.708 | -14.09 | 9.609 | 9.902 | 7.09 | 7.2 |
| Earnings Per Share | -1.863 | -9.52 | -2.125 | -2.213 | -3.295 | -2.359 |
| Cash Per Share | 17.901 | 9.587 | 10.371 | 4.748 | 1.605 | 5.827 |
| Working Capital Per Share | 16.78 | 7.637 | 9.966 | 7.446 | 6.276 | 6.494 |
| Operating Profit Per Share | 2.757 | 1.349 | 0.51 | 0.56 | 0.096 | 0.485 |
| EBIT Per Share | -1.863 | -9.52 | -2.125 | -2.213 | -3.295 | -2.359 |
| EBITDA Per Share | -1.863 | -9.52 | -2.125 | -2.213 | -3.295 | -2.359 |
| Free Cash Flow Per Share | -1.918 | -9.096 | -2.141 | -1.978 | -3.015 | -2.392 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 5.13M | 5.18M | 26.68M | 32.23M | 32.63M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | 32.63M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | -9624.832 | N/A | N/A | N/A | -115717.857 | N/A | N/A |
| Net Profit Margin (%) | N/A | -9624.832 | N/A | N/A | N/A | -115717.857 | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 218.19M |
| Price to Earnings Ratio | -2.11 |
| Price to Sales Ratio | 10.26 |
| Price to Cash Ratio | 0.85 |
| Price to Book Ratio | 0.69 |
| Dividend Yield | - |
| Shares Outstanding | 46.23M |
| Average Volume (1 week) | 586.57k |
| Average Volume (1 Month) | 780.49k |
| 52 Week Change | -74.40% |
| 52 Week High | 36.25 |
| 52 Week Low | 4.48 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
